ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Down 16.1% – Here’s What Happened

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) dropped 16.1% during mid-day trading on Wednesday. The stock traded as low as $11.41 and last traded at $11.48. 145,743 shares traded hands during mid-day trading, a decline of 34% from the average daily volume of 221,623 shares. The stock had previously closed at $13.68.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CHRN shares. Northland Securities started coverage on ChronoScale Corporation Common Stock in a research note on Friday, September 18th. They issued an “outperform” rating and a $32.00 target price on the stock. Compass Point started coverage on ChronoScale Corporation Common Stock in a research report on Friday, October 16th. They set a “buy” rating and a $25.00 price target for the company. Finally, Weiss Ratings cut ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a research report on Friday, October 23rd. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, ChronoScale Corporation Common Stock has an average rating of “Hold” and an average price target of $21.00.

ChronoScale Corporation Common Stock Stock Performance

The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.30 and a current ratio of 0.30. The firm’s 50 day moving average is $17.82 and its 200-day moving average is $16.04. The stock has a market capitalization of $1.57 billion, a price-to-earnings ratio of -2.49 and a beta of 1.12.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its quarterly earnings results on Wednesday, October 14th. The company reported ($0.29) earnings per share (EPS) for the quarter. The firm had revenue of $41.48 million for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. Analysts forecast that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current fiscal year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.